Humacyte, Inc.
HUMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001818382
In the last 90 days, Humacyte, Inc. insiders filed 3 open-market purchases and 0 sales; 164 institutions reported holding it in 13F filings for Q2 2026, worth $57.3M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Humacyte, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 83 | 88 | +5 |
| Shares | 16.6M | 17.8M | +1.21M (+7.3%) |
| Value | $48.7M | $50.7M | +$1.98M (+4.1%) |
New holders (11)
Institutions that held Humacyte, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 51,200 | $145.4K | 0.00% |
| AQR Capital Management LLC | 43,337 | $123.1K | 0.00% |
| EntryPoint Capital, LLC | 32,907 | $93.5K | 0.09% |
| Brevan Howard Capital Management LP | 31,018 | $88.1K | 0.01% |
| D. E. Shaw & Co., Inc. | 22,540 | $64.0K | 0.00% |
| Kovitz Investment Group Partners, LLC | 12,250 | $34.8K | 0.00% |
| Victory Capital Management Inc | 10,099 | $28.7K | 0.00% |
| Whittier Trust Co of Nevada Inc | 10,000 | $28.3K | 0.00% |
| O'Dell Group, LLC | 1,500 | $4.26K | 0.00% |
| GAMMA Investing LLC | 112 | $372 | 0.00% |
| CWM, LLC | 11 | $0 | 0.00% |
Sold out (6)
Institutions that held Humacyte, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Rokos Capital Management LLP | 200,000 | $587.0K |
| Kovack Advisors, Inc. | 42,000 | $123.1K |
| Verition Fund Management LLC | 39,356 | $115.3K |
| Private Management Group Inc | 15,500 | $45.4K |
| Bayesian Capital Management, LP | 12,641 | $37.0K |
| Allspring Global Investments Holdings, LLC | 3,885 | $11.4K |